Entrada Therapeutics Inc (TRDA)

Stock price, financials, and technical signals for Entrada Therapeutics Inc (TRDA).

$8.02

-0.78

(-8.86%)

As of 04/03/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

TRDA Performance Snapshot


1-Week Chg

-19.48%

1-Month Chg

-29.21%

3-Month Chg

-56.20%

6-Month Chg

-51.22%

1-Year Chg

-41.93%

Year-To-Date Chg

-54.07%

Beta 1-Year

2.59

Beta 5-Year

0.06

Volatility (10-Day)

8.71%

TRDA Technicals



TRDA Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $105.16M

    46.97%

  • Total assets

    $526.32M

    12.18%

  • Total liabilities

    $97.64M

    -56.95%

  • Total investments

    $318.79M

    12.10%

  • Shareholders' equity

    $428.68M

    76.88%

  • Book value per share

    $10.49

    44.44%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $37.40M

    -10.63%

  • Net income

    $1.13M

    111.85%

  • Operating expense

    $43.27M

    17.11%

  • Gross profit

    $37.40M

    -10.63%

  • EBITDA

    $253.00K

    -97.45%

  • Earnings per share

    -$0.03

    89.66%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    $23.16M

    47.34%

  • Cash from operations

    -$31.61M

    -687.57%

  • Cash from investing

    $53.37M

    180.23%

  • Cash from financing

    $1.40M

    103.19%

  • Free cash flow

    -$32.24M

    -546.22%

  • Free cash flow per share

    -$0.79

    -429.53%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $646.99M

    28.49%

  • Enterprise value

    $626.31M

    21.20%

  • Shares outstanding

    37.42M

    12.14%

  • Profit margin

    3.00%

    113.16%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    0.70%

    -97.05%


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    11.14

    378.53%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.